Exagen Aktie
WKN DE: A2PRXT / ISIN: US30068X1037
29.07.2025 14:08:56
|
Exagen Inc Q2 Loss Increases, Misses Estimates
(RTTNews) - Exagen Inc (XGN) announced Loss for its second quarter that increased from last year and missed the Street estimates.
The company's earnings totaled -$4.44 million, or -$0.21 per share. This compares with -$2.97 million, or -$0.16 per share, last year.
Analysts on average had expected the company to earn -$0.15 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 14.2% to $17.20 million from $15.06 million last year.
Exagen Inc earnings at a glance (GAAP) :
-Earnings: -$4.44 Mln. vs. -$2.97 Mln. last year. -EPS: -$0.21 vs. -$0.16 last year. -Revenue: $17.20 Mln vs. $15.06 Mln last year.
-Guidance: Full year revenue guidance: $65 Mln - $70 Mln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Exagen Inc Registered Shsmehr Nachrichten
28.07.25 |
Ausblick: Exagen gewährt Anlegern Blick in die Bücher (finanzen.net) |
Analysen zu Exagen Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Exagen Inc Registered Shs | 8,15 | 4,49% |
|